PYC Equity Raising to Raise up to $146 Million
Filed with ASX · · 7 pages · English
PYC Therapeutics Limited on 6ix
In the deck
Story so far
Earlier from PYC Therapeutics
- Approval to Commence Human Trials in Kidney Program
- ADOA Safety Review Committee Approves Dose Escalation
- US FDA Grants Rare Pediatric Disease Designation to VP-001
- PYC Nominates Fourth Clinical Drug Candidate in PMS Program
- PYC to Progress Kidney Drug Candidate Into Human Trials
Later from PYC Therapeutics
- PYC Equity Raising Presentation
- Completion of Institutional Entitlement Offer
- Retail Entitlement Offer Booklet
- Placement of Shortfall
- First Subject Dosed in PKD Clinical Trial
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics